INVESCO LTD (IVZ) Stock Fundamental Analysis
USA - NYSE:IVZ - BMG491BT1088 - Common Stock
23.37 USD
+0.13 (+0.56%)
23 USD
-0.37 (-1.58%)
IVZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. IVZ may be in some trouble as it scores bad on both profitability and health. IVZ has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year IVZ was profitable.
IVZ had a positive operating cash flow in the past year.
Of the past 5 years IVZ 4 years were profitable.
Each year in the past 5 years IVZ had a positive operating cash flow.
1.2 Ratios
IVZ has a Return On Assets of 2.35%. This is comparable to the rest of the industry: IVZ outperforms 44.73% of its industry peers.
IVZ's Return On Equity of 4.77% is on the low side compared to the rest of the industry. IVZ is outperformed by 62.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.35% | ||
| ROE | 4.77% | ||
| ROIC | N/A |
ROA(3y)1.05%
ROA(5y)1.77%
ROE(3y)1.97%
ROE(5y)3.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IVZ has a Profit Margin (10.64%) which is in line with its industry peers.
IVZ's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 17.11%, IVZ is not doing good in the industry: 61.18% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of IVZ has declined.
The Gross Margin of IVZ (66.64%) is better than 75.11% of its industry peers.
In the last couple of years the Gross Margin of IVZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.11% | ||
| PM (TTM) | 10.64% | ||
| GM | 66.64% |
OM growth 3Y-18.12%
OM growth 5Y-10.75%
PM growth 3Y-24%
PM growth 5Y-0.8%
GM growth 3Y-1.08%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
IVZ has less shares outstanding than it did 1 year ago.
IVZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IVZ has been reduced compared to a year ago.
2.2 Solvency
IVZ has a debt to FCF ratio of 7.13. This is a slightly negative value and a sign of low solvency as IVZ would need 7.13 years to pay back of all of its debts.
IVZ has a Debt to FCF ratio of 7.13. This is in the better half of the industry: IVZ outperforms 62.45% of its industry peers.
IVZ has a Debt/Equity ratio of 0.71. This is a neutral value indicating IVZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, IVZ is in line with its industry, outperforming 59.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 7.13 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
IVZ has a Current Ratio of 0.75. This is a bad value and indicates that IVZ is not financially healthy enough and could expect problems in meeting its short term obligations.
IVZ's Current ratio of 0.75 is on the low side compared to the rest of the industry. IVZ is outperformed by 68.35% of its industry peers.
A Quick Ratio of 0.75 indicates that IVZ may have some problems paying its short term obligations.
IVZ's Quick ratio of 0.75 is on the low side compared to the rest of the industry. IVZ is outperformed by 67.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.75 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.57% over the past year.
IVZ shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.57% yearly.
The Revenue has been growing slightly by 6.63% in the past year.
Measured over the past years, IVZ shows a decrease in Revenue. The Revenue has been decreasing by -0.17% on average per year.
EPS 1Y (TTM)15.57%
EPS 3Y-17.74%
EPS 5Y-7.57%
EPS Q2Q%38.64%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y-4.17%
Revenue growth 5Y-0.17%
Sales Q2Q%7.43%
3.2 Future
IVZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.17% yearly.
IVZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.02% yearly.
EPS Next Y14.83%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
EPS Next 5Y15.17%
Revenue Next Year5.14%
Revenue Next 2Y8.14%
Revenue Next 3Y7.02%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.11, IVZ is valued correctly.
The rest of the industry has a similar Price/Earnings ratio as IVZ.
IVZ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.13.
The Price/Forward Earnings ratio is 9.20, which indicates a very decent valuation of IVZ.
Based on the Price/Forward Earnings ratio, IVZ is valued a bit cheaper than 74.68% of the companies in the same industry.
IVZ's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 9.2 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVZ is valued a bit cheaper than the industry average as 76.79% of the companies are valued more expensively.
IVZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IVZ is cheaper than 78.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.48 | ||
| EV/EBITDA | 16.19 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IVZ's earnings are expected to grow with 18.86% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y18.86%
5. Dividend
5.1 Amount
IVZ has a Yearly Dividend Yield of 3.56%. Purely for dividend investing, there may be better candidates out there.
IVZ's Dividend Yield is comparable with the industry average which is at 8.57.
IVZ's Dividend Yield is a higher than the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.56% |
5.2 History
The dividend of IVZ decreases each year by -2.49%.
IVZ has paid a dividend for at least 10 years, which is a reliable track record.
IVZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-2.49%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
IVZ pays out 22.75% of its income as dividend. This is a sustainable payout ratio.
DP22.75%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
23.37
+0.13 (+0.56%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-0.37%
Ins Owners0.69%
Ins Owner Change0.54%
Market Cap10.42B
Revenue(TTM)6.28B
Net Income(TTM)668.00M
Analysts69.47
Price Target25.85 (10.61%)
Short Float %3.81%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.56% |
Yearly Dividend1.35
Dividend Growth(5Y)-2.49%
DP22.75%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.27%
Min EPS beat(2)-12.91%
Max EPS beat(2)33.45%
EPS beat(4)3
Avg EPS beat(4)10.77%
Min EPS beat(4)-12.91%
Max EPS beat(4)33.45%
EPS beat(8)6
Avg EPS beat(8)6.33%
EPS beat(12)8
Avg EPS beat(12)2.97%
EPS beat(16)9
Avg EPS beat(16)-0.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.91%
Revenue beat(12)3
Avg Revenue beat(12)3.37%
Revenue beat(16)7
Avg Revenue beat(16)9.27%
PT rev (1m)9.34%
PT rev (3m)46.93%
EPS NQ rev (1m)-1.2%
EPS NQ rev (3m)-2.94%
EPS NY rev (1m)1.76%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)1.03%
Revenue NQ rev (3m)2.43%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 9.2 | ||
| P/S | 1.66 | ||
| P/FCF | 7.48 | ||
| P/OCF | 7.51 | ||
| P/B | 0.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.19 |
EPS(TTM)1.93
EY8.26%
EPS(NY)2.54
Fwd EY10.87%
FCF(TTM)3.13
FCFY13.38%
OCF(TTM)3.11
OCFY13.31%
SpS14.08
BVpS31.41
TBVpS-0.41
PEG (NY)0.82
PEG (5Y)N/A
Graham Number36.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.35% | ||
| ROE | 4.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 17.11% | ||
| PM (TTM) | 10.64% | ||
| GM | 66.64% | ||
| FCFM | 22.21% |
ROA(3y)1.05%
ROA(5y)1.77%
ROE(3y)1.97%
ROE(5y)3.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.86%
ROCE(5y)4.54%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.12%
OM growth 5Y-10.75%
PM growth 3Y-24%
PM growth 5Y-0.8%
GM growth 3Y-1.08%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 7.13 | ||
| Debt/EBITDA | 7.93 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 110.61% | ||
| Profit Quality | 208.68% | ||
| Current Ratio | 0.75 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | N/A |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)75.57%
Cap/Depr(5y)67.25%
Cap/Sales(3y)2.4%
Cap/Sales(5y)2.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.57%
EPS 3Y-17.74%
EPS 5Y-7.57%
EPS Q2Q%38.64%
EPS Next Y14.83%
EPS Next 2Y21.53%
EPS Next 3Y18.86%
EPS Next 5Y15.17%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y-4.17%
Revenue growth 5Y-0.17%
Sales Q2Q%7.43%
Revenue Next Year5.14%
Revenue Next 2Y8.14%
Revenue Next 3Y7.02%
Revenue Next 5YN/A
EBIT growth 1Y54.76%
EBIT growth 3Y-21.54%
EBIT growth 5Y-10.89%
EBIT Next Year16.45%
EBIT Next 3Y13.36%
EBIT Next 5Y9.47%
FCF growth 1Y63.44%
FCF growth 3Y4.97%
FCF growth 5Y2.62%
OCF growth 1Y32.1%
OCF growth 3Y3.35%
OCF growth 5Y1.42%
INVESCO LTD / IVZ FAQ
What is the fundamental rating for IVZ stock?
ChartMill assigns a fundamental rating of 4 / 10 to IVZ.
What is the valuation status for IVZ stock?
ChartMill assigns a valuation rating of 6 / 10 to INVESCO LTD (IVZ). This can be considered as Fairly Valued.
What is the profitability of IVZ stock?
INVESCO LTD (IVZ) has a profitability rating of 3 / 10.
What are the PE and PB ratios of INVESCO LTD (IVZ) stock?
The Price/Earnings (PE) ratio for INVESCO LTD (IVZ) is 12.11 and the Price/Book (PB) ratio is 0.74.
How sustainable is the dividend of INVESCO LTD (IVZ) stock?
The dividend rating of INVESCO LTD (IVZ) is 5 / 10 and the dividend payout ratio is 22.75%.